
Opinion|Videos|August 26, 2024
Comprehensive Insights into the Historical and Modern Treatment Strategies for BPH
Fact checked by: Dean Elterman, MD, MSc
Dean Elterman, MD, discusses historical treatment options for BPH, including both pharmacotherapy and surgical methods, their effectiveness, and how to identify patients who would benefit from treatment based on quality of life, risk of lower urinary tract symptoms, and other factors. It also addresses challenges such as long-term complications and patient adherence.
Advertisement
Episodes in this series

Now Playing
Video content above is prompted by the following:
- Historically, how has benign prostate dysplasia (BPH) been treated?
- Please speak to both pharmacotherapy and surgical options.
- How effective have those treatments been?
- The course of BPH in an individual is not often predictable. According to some studies, symptoms and measurements of urethral obstruction can remain stable for many years and may even improve for as many as one-third of patients.
- How do you determine which patients would benefit from treatment?
- Quality of life issues, risk of developing lower urinary tract symptoms, other adverse events
- What factors may indicate that a patient is a promising candidate for pharmacotherapy, or, conversely, they are a promising candidate for surgery?
- What are some of the main challenges with these treatments (long-term complications, patient adherence, etc)?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Clinical Application of MMAI Score in Patients with Prostate Cancer
2
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
3
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
4
Benjamin Lowentritt, MD, reviews real-world testosterone recovery data with relugolix
5







